Literature DB >> 15124137

Advances in follicular lymphoma.

Travis D Archuleta1, James O Armitage.   

Abstract

Follicular lymphoma is a usually indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15124137     DOI: 10.1053/j.seminoncol.2004.02.007

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  4 in total

1.  Follicular lymphoma with extensive gastrointestinal tract involvement: follow-up by capsule endoscopy.

Authors:  Boris Sapoznikov; Sarah Morgenstern; Pia Raanani; Adina Aviram; Esther Rabizadeh; Miron Prokocimer; Yaron Niv
Journal:  Dig Dis Sci       Date:  2007-03-13       Impact factor: 3.199

2.  Antiproliferative Properties of Type I and Type II Interferon.

Authors:  Joseph Bekisz; Samuel Baron; Corey Balinsky; Angel Morrow; Kathryn C Zoon
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-30

3.  Characterization of follicular lymphoma in the small intestine using double-balloon endoscopy.

Authors:  Manzurul Chowdhury; Masaki Endo; Toshimi Chiba; Norihiko Kudara; Shuhei Oana; Kunihiko Sato; Risaburo Akasaka; Kazumitsu Tomita; Saori Fujiwara; Tomomi Mizutani; Tamotsu Sugai; Yasuhiro Takikawa; Kazuyuki Suzuki
Journal:  Gastroenterol Res Pract       Date:  2009-11-05       Impact factor: 2.260

4.  Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma.

Authors:  John Hornberger; Carolina Reyes; Deborah Lubeck; Nancy Valente
Journal:  Leuk Lymphoma       Date:  2008-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.